Aurobindo Pharma is making a strategic move to broaden its pharmaceutical business within the dynamic Latin American market. The company has officially incorporated a new subsidiary in Chile through its wholly owned stepdown subsidiary, Eugia Pharma B.V.
This new Chilean entity, named Eugia Pharma Chile SpA, was established with an initial capital subscription of 1,000,000 Chilean Pesos (approximately $1,050), distributed as 100 shares. This incorporation sets the stage for expanding the company’s product reach in the country.
This latest expansion into Chile builds on recent international growth efforts by Aurobindo Pharma. Just last month, the company, via its subsidiary CuraTeQ Biologics B.V., also set up a new subsidiary in Malta. Both initiatives reflect Aurobindo Pharma’s ongoing commitment to strengthening its global presence and diversifying its pharmaceutical product offerings.